Sean Harper an Insider in Amgen Inc. (AMGN) Unloaded 1,525 Shares of the Company; Summit Hotel Properties (INN)’s Sentiment Is 1.25

Summit Hotel Properties, Inc. (NYSE:INN) Logo

Sentiment for Summit Hotel Properties Inc (INN)

Summit Hotel Properties Inc (INN) investors sentiment increased to 1.25 in Q4 2017. It’s up 0.27, from 0.98 in 2017Q3. The ratio is better, as 111 investment managers increased or opened new positions, while 89 sold and decreased their positions in Summit Hotel Properties Inc. The investment managers in our database now hold: 101.33 million shares, up from 99.13 million shares in 2017Q3. Also, the number of investment managers holding Summit Hotel Properties Inc in top ten positions was flat from 0 to 0 for the same number . Sold All: 24 Reduced: 65 Increased: 82 New Position: 29.

Analysts await Amgen Inc. (NASDAQ:AMGN) to report earnings on April, 26 after the close. They expect $3.22 EPS, up 2.22% or $0.07 from last year’s $3.15 per share. AMGN’s profit will be $2.15 billion for 13.31 P/E if the $3.22 EPS becomes a reality. After $2.89 actual EPS reported by Amgen Inc. for the previous quarter, Wall Street now forecasts 11.42% EPS growth.

Since December 12, 2017, it had 0 insider purchases, and 4 insider sales for $1.11 million activity. Harper Sean E sold $283,071 worth of Amgen Inc. (NASDAQ:AMGN) on Tuesday, January 16.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company has market cap of $114.53 billion. It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. It has a 63.71 P/E ratio. The company's products include Evenity to treat osteoporosis in postmenopausal women; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Repatha to treat coronary artery diseases; Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Parsabiv to treat secondary hyperparathyroidism ; and Erenumab for the prevention of migraine.

Investors sentiment increased to 1.22 in Q4 2017. Its up 0.23, from 0.99 in 2017Q3. It is positive, as 73 investors sold Amgen Inc. shares while 458 reduced holdings. 122 funds opened positions while 527 raised stakes. 551.71 million shares or 0.60% less from 555.05 million shares in 2017Q3 were reported. Moreover, Kdi Cap Ptnrs Lc has 3.17% invested in Amgen Inc. (NASDAQ:AMGN) for 45,865 shares. Boulegeris Investments stated it has 0.12% of its portfolio in Amgen Inc. (NASDAQ:AMGN). Personal Capital Corporation owns 0.39% invested in Amgen Inc. (NASDAQ:AMGN) for 131,385 shares. Davis R M invested 0.04% of its portfolio in Amgen Inc. (NASDAQ:AMGN). Tiaa Cref Invest Mgmt Limited Liability Corporation accumulated 3.22 million shares. Fishman Jay A Limited Mi invested in 2.15% or 65,495 shares. Cetera Advisor Ltd Liability Corp has 21,359 shares. Bnp Paribas Asset Mgmt Hldgs Sa has invested 0.18% in Amgen Inc. (NASDAQ:AMGN). Seabridge Inv Advsr Lc owns 18,753 shares. Capital City Trust Fl owns 5,075 shares. American Tru Advsrs Lc reported 0.41% of its portfolio in Amgen Inc. (NASDAQ:AMGN). Blackrock holds 0.41% of its portfolio in Amgen Inc. (NASDAQ:AMGN) for 49.43 million shares. Crawford Invest Counsel reported 7,001 shares stake. Rfg Advisory Group Limited Co holds 0.4% or 4,699 shares in its portfolio. Stearns Svcs Grp invested in 0.19% or 4,644 shares.

Yesterday, the EVP – Research & Development of Amgen Inc, Mr. Sean Harper, made a sale of amount company shares – 1,525, totalling $263,337 U.S. Dollars, estimated based on $172.7 for share. He also unloaded 1,525 shares with a total value of about $289,369 USD in the last month. Mr. Sean currently has ownership of 56,788 shares, accounting for 0.01% of Amgen Inc’s stock market cap.

The stock decreased 0.06% or $0.1 during the last trading session, reaching $171.38. About 2.13M shares traded. Amgen Inc. (NASDAQ:AMGN) has risen 3.78% since April 17, 2017 and is uptrending. It has underperformed by 7.77% the S&P500.

Among 25 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 14 Hold. Therefore 44% are positive. Amgen Inc. has $220 highest and $160 lowest target. $193.16’s average target is 12.71% above currents $171.38 stock price. Amgen Inc. had 88 analyst reports since August 3, 2015 according to SRatingsIntel. Bernstein maintained Amgen Inc. (NASDAQ:AMGN) on Wednesday, June 7 with “Hold” rating. The stock of Amgen Inc. (NASDAQ:AMGN) earned “Outperform” rating by RBC Capital Markets on Friday, July 31. The firm earned “Buy” rating on Wednesday, February 1 by Bank of America. The stock of Amgen Inc. (NASDAQ:AMGN) earned “Overweight” rating by Morgan Stanley on Tuesday, December 15. The stock has “Overweight” rating by Atlantic Securities on Friday, December 18. The stock of Amgen Inc. (NASDAQ:AMGN) earned “Hold” rating by Atlantic Securities on Monday, February 5. Piper Jaffray maintained the shares of AMGN in report on Saturday, August 29 with “Overweight” rating. The firm has “Buy” rating given on Friday, August 21 by Vetr. On Friday, July 21 the stock rating was maintained by BMO Capital Markets with “Buy”. The stock has “Overweight” rating by Piper Jaffray on Thursday, November 5.

The stock increased 1.46% or $0.21 during the last trading session, reaching $14.61. About 783,449 shares traded. Summit Hotel Properties, Inc. (INN) has declined 15.85% since April 17, 2017 and is downtrending. It has underperformed by 27.40% the S&P500.

Analysts await Summit Hotel Properties, Inc. (NYSE:INN) to report earnings on May, 2 after the close. They expect $0.30 EPS, down 6.25% or $0.02 from last year’s $0.32 per share. INN’s profit will be $31.50 million for 12.18 P/E if the $0.30 EPS becomes a reality. After $0.30 actual EPS reported by Summit Hotel Properties, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Heitman Real Estate Securities Llc holds 1.87% of its portfolio in Summit Hotel Properties, Inc. for 2.16 million shares. Banced Corp owns 36,020 shares or 0.91% of their US portfolio. Moreover, Grace & White Inc Ny has 0.74% invested in the company for 242,049 shares. The Illinois-based Nuveen Asset Management Llc has invested 0.56% in the stock. Monarch Partners Asset Management Llc, a Massachusetts-based fund reported 355,097 shares.

Summit Hotel Properties, Inc., a hotel investment company, engages in acquiring, owning, renovating, repositioning, and asset-managing and selling premium-branded limited-service and select-service hotels in the upscale and midscale without food and beverage divisions of the United StatesÂ’ lodging industry. The company has market cap of $1.53 billion. As of August 3, 2012, the firm operated 74 hotels with a total of 7,586 guestrooms located in 20 states. It has a 18.49 P/E ratio.

Summit Hotel Properties, Inc. (NYSE:INN) Institutional Positions Chart